Nyxoah S.A.
NASDAQ:NYXHMedical - Instruments & Supplies
+$0.02 today
- Market cap
- $87.89M
- Beta
- 0.89
- P/E (TTM)
- -0.7
- EPS (TTM)
- -$1.99
Volume 0.17M
Average 0.22M
NYXH Inventory
Raw materials, work in progress, and finished goods held for sale.
Nyxoah S.A.NASDAQ: NYXH
Inventory · Q1 FY2026 · quarter ended Mar 2026
Inventory falls 12.4% from a year ago
Inventory stood at €4.36M at the end of Q1 FY2026, down 12.4% from a year earlier and down 6.3% from the prior quarter. Over 3 fiscal years it compounded at +74.1% a year.
Context
- Inventory amounted to 4.5% of total assets at the end of Q1 FY2026, up 0.8 pp from a year earlier.
- Inventory increased in 2 of the last 3 fiscal years.
What to watch
Whether inventory keeps falling in the next quarterly balance sheet after a -12.4% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Inventory history
EUR · from the balance sheet
- Latest · FY2025
- 4.66M EUR
- Year-over-year change
- -1.2%
- 4-year CAGR
- +91.6%
| Period | Period end | Inventory | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 4.66M | -1.2% |
| FY2024 | 2024-12-31 | 4.72M | +42.3% |
| FY2023 | 2023-12-31 | 3.32M | +275.9% |
| FY2022 | 2022-12-31 | 882K | +154.9% |
| FY2021 | 2021-12-31 | 346K | — |
Inventory vs competitors
How NYXH compares with its peers on the latest reported figures
- Peers report in different currencies, so inventory is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of -12.4% is the 6th highest of 7, against a peer median of +26.2%.
- Inventory amounts to 4.5% of total assets for NYXH, versus a peer median of 7.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $30.31M USD | -15.1% | -31.3% | 8.0% | |
| Mar 2026 | $25.45M USD | +5658.4% | — | 10.5% | |
| Mar 2026 | $14.2M USD | +114.8% | +15.9% | 8.1% | |
| Mar 2026 | $8.72M USD | +0.9% | -3.4% | 7.0% | |
| Mar 2026 | $4.72M USD | +15.9% | -21.4% | 3.8% | |
| Mar 2026 | $4.48M USD | +36.5% | -16.9% | 15.7% | |
| Mar 2026 | €4.36M EUR | -12.4% | +74.1% | 4.5% | |
| Mar 2026 | $0 USD | — | — | 0.0% | |
| Mar 2026 | $0 USD | — | — | 0.0% | |
| Mar 2026 | $0 USD | — | — | 0.0% | |
| Peer median (excluding NYXH) | — | +26.2% | -16.9% | 7.0% | |
Competitors are the stored peer set for NYXH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 135.51M | 17.89M | 21.61M | 34.19M | 29.99M |
| Short-term Investments | 0 | 76.97M | 36.14M | 51.37M | 17.99M |
| Net Receivables | 2.51M | 2.23M | 5.63M | 6.16M | 7.72M |
| Inventory | 346K | 882K | 3.32M | 4.72M | 4.66M |
| Other Current Assets | 3.98M | 828K | 1.66M | 918K | 827.69K |
| Total Current Assets | 140.06M | 100.26M | 68.35M | 98.08M | 61.19M |
| Property, Plant & Equipment (Net) | 5.24M | 5.62M | 7.98M | 8.25M | 5.34M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 25.32M | 39.97M | 46.61M | 50.38M | 50.09M |
| Long-term Investments | 164K | 173K | 0 | 0 | 1.72M |
| Tax Assets | 46K | 47K | 56K | 76K | 86.97K |
| Other Non-current Assets | 0 | 0 | 1.17M | 1.62M | 0 |
| Total Non-current Assets | 30.77M | 45.81M | 55.81M | 60.32M | 57.24M |
| Total Assets | 170.83M | 146.07M | 124.16M | 158.41M | 118.43M |
| Account Payables | 2.39M | 1.87M | 4.1M | 3.75M | 13.72M |
| Short-term Debt | 554K | 389K | 364K | 248K | 23.76M |
| Tax Payables | 2.81M | 3.65M | 1.99M | 4.32M | 0 |
| Deferred Revenue | 0 | 0 | 0 | 117K | 893.66K |
| Other Current Liabilities | 1.15M | 621K | 1.08M | 2.36M | 6.63M |
| Total Current Liabilities | 11.57M | 14.91M | 14.44M | 21.53M | 48.94M |
| Long-term Debt | 7.8M | 8.19M | 8.37M | 18.73M | 17.66M |
| Deferred Tax Liabilities | 5K | 0 | 9K | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 680.74K |
| Other Non-current Liabilities | 92K | 59K | 194K | 2.34M | 1.4M |
| Total Non-current Liabilities | 10.64M | 10.83M | 11.69M | 23.62M | 20.38M |
| Total Liabilities | 22.21M | 25.75M | 26.14M | 45.15M | 69.34M |
| Common Stock | 4.43M | 4.44M | 4.93M | 6.43M | 6.5M |
| Retained Earnings | (87.17M) | (118.21M) | (160.83M) | (217.74M) | (305.91M) |
| Accumulated OCI | 202K | 176K | 137K | 10.21M | 13.51M |
| Other Stockholders Equity | 3.13M | 5.65M | 7.66M | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 148.62M | 120.32M | 98.02M | 113.25M | 49.11M |
| Total Debt | 11.68M | 11.88M | 12.7M | 22.65M | 42.06M |
| Net Debt | (123.83M) | (6.01M) | (8.91M) | (11.53M) | 12.07M |
Nyxoah S.A.
NASDAQ:NYXH
Intrinsic Alpha fair value
Locked
Current Price
$0.86
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.